1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Personalized Medicines Market Perspective (2016-2027)
2.2 Personalized Medicines Growth Trends by Regions
2.2.1 Personalized Medicines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Medicines Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Medicines Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Medicines Industry Dynamic
2.3.1 Personalized Medicines Market Trends
2.3.2 Personalized Medicines Market Drivers
2.3.3 Personalized Medicines Market Challenges
2.3.4 Personalized Medicines Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines Players by Revenue
3.1.1 Global Top Personalized Medicines Players by Revenue (2016-2021)
3.1.2 Global Personalized Medicines Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines Revenue
3.4 Global Personalized Medicines Market Concentration Ratio
3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2020
3.5 Personalized Medicines Key Players Head office and Area Served
3.6 Key Players Personalized Medicines Product Solution and Service
3.7 Date of Enter into Personalized Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicines Breakdown Data by Type
4.1 Global Personalized Medicines Historic Market Size by Type (2016-2021)
4.2 Global Personalized Medicines Forecasted Market Size by Type (2022-2027)

5 Personalized Medicines Breakdown Data by Application
5.1 Global Personalized Medicines Historic Market Size by Application (2016-2021)
5.2 Global Personalized Medicines Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Personalized Medicines Market Size (2016-2027)
6.2 North America Personalized Medicines Market Size by Type
6.2.1 North America Personalized Medicines Market Size by Type (2016-2021)
6.2.2 North America Personalized Medicines Market Size by Type (2022-2027)
6.2.3 North America Personalized Medicines Market Size by Type (2016-2027)
6.3 North America Personalized Medicines Market Size by Application
6.3.1 North America Personalized Medicines Market Size by Application (2016-2021)
6.3.2 North America Personalized Medicines Market Size by Application (2022-2027)
6.3.3 North America Personalized Medicines Market Size by Application (2016-2027)
6.4 North America Personalized Medicines Market Size by Country
6.4.1 North America Personalized Medicines Market Size by Country (2016-2021)
6.4.2 North America Personalized Medicines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Personalized Medicines Market Size (2016-2027)
7.2 Europe Personalized Medicines Market Size by Type
7.2.1 Europe Personalized Medicines Market Size by Type (2016-2021)
7.2.2 Europe Personalized Medicines Market Size by Type (2022-2027)
7.2.3 Europe Personalized Medicines Market Size by Type (2016-2027)
7.3 Europe Personalized Medicines Market Size by Application
7.3.1 Europe Personalized Medicines Market Size by Application (2016-2021)
7.3.2 Europe Personalized Medicines Market Size by Application (2022-2027)
7.3.3 Europe Personalized Medicines Market Size by Application (2016-2027)
7.4 Europe Personalized Medicines Market Size by Country
7.4.1 Europe Personalized Medicines Market Size by Country (2016-2021)
7.4.2 Europe Personalized Medicines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines Market Size (2016-2027)
8.2 Asia-Pacific Personalized Medicines Market Size by Type
8.2.1 Asia-Pacific Personalized Medicines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Medicines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Medicines Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Medicines Market Size by Application
8.3.1 Asia-Pacific Personalized Medicines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Medicines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Medicines Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Medicines Market Size by Region
8.4.1 Asia-Pacific Personalized Medicines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Medicines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Personalized Medicines Market Size (2016-2027)
9.2 Latin America Personalized Medicines Market Size by Type
9.2.1 Latin America Personalized Medicines Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Medicines Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Medicines Market Size by Type (2016-2027)
9.3 Latin America Personalized Medicines Market Size by Application
9.3.1 Latin America Personalized Medicines Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Medicines Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Medicines Market Size by Application (2016-2027)
9.4 Latin America Personalized Medicines Market Size by Country
9.4.1 Latin America Personalized Medicines Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Medicines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines Market Size (2016-2027)
10.2 Middle East & Africa Personalized Medicines Market Size by Type
10.2.1 Middle East & Africa Personalized Medicines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Medicines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Medicines Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Medicines Market Size by Application
10.3.1 Middle East & Africa Personalized Medicines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Medicines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Medicines Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Medicines Market Size by Country
10.4.1 Middle East & Africa Personalized Medicines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Medicines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 3G Biotech
11.1.1 3G Biotech Company Details
11.1.2 3G Biotech Business Overview
11.1.3 3G Biotech Personalized Medicines Introduction
11.1.4 3G Biotech Revenue in Personalized Medicines Business (2016-2021)
11.1.5 3G Biotech Recent Development
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Personalized Medicines Introduction
11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2016-2021)
11.2.5 Quest Diagnostics Recent Development
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Company Details
11.3.2 Laboratory Corporation of America Business Overview
11.3.3 Laboratory Corporation of America Personalized Medicines Introduction
11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2016-2021)
11.3.5 Laboratory Corporation of America Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Personalized Medicines Introduction
11.4.4 Abbott Revenue in Personalized Medicines Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Agendia NV
11.5.1 Agendia NV Company Details
11.5.2 Agendia NV Business Overview
11.5.3 Agendia NV Personalized Medicines Introduction
11.5.4 Agendia NV Revenue in Personalized Medicines Business (2016-2021)
11.5.5 Agendia NV Recent Development
11.6 Asuragen Inc
11.6.1 Asuragen Inc Company Details
11.6.2 Asuragen Inc Business Overview
11.6.3 Asuragen Inc Personalized Medicines Introduction
11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2016-2021)
11.6.5 Asuragen Inc Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Personalized Medicines Introduction
11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2016-2021)
11.7.5 Becton Dickinson Recent Development
11.8 CardioDx Inc.
11.8.1 CardioDx Inc. Company Details
11.8.2 CardioDx Inc. Business Overview
11.8.3 CardioDx Inc. Personalized Medicines Introduction
11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2016-2021)
11.8.5 CardioDx Inc. Recent Development
11.9 Foundation Medicine
11.9.1 Foundation Medicine Company Details
11.9.2 Foundation Medicine Business Overview
11.9.3 Foundation Medicine Personalized Medicines Introduction
11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2016-2021)
11.9.5 Foundation Medicine Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Personalized Medicines Introduction
11.10.4 Qiagen Revenue in Personalized Medicines Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Personalized Medicines Introduction
11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2016-2021)
11.11.5 Siemens Healthcare Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Personalized Medicines Introduction
11.12.4 Amgen Revenue in Personalized Medicines Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2016-2021)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 GE Healthcare
11.14.1 GE Healthcare Company Details
11.14.2 GE Healthcare Business Overview
11.14.3 GE Healthcare Personalized Medicines Introduction
11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2016-2021)
11.14.5 GE Healthcare Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Personalized Medicines Introduction
11.15.4 Pfizer Revenue in Personalized Medicines Business (2016-2021)
11.15.5 Pfizer Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Personalized Medicines Introduction
11.16.4 Sanofi Revenue in Personalized Medicines Business (2016-2021)
11.16.5 Sanofi Recent Development
11.17 23andMe
11.17.1 23andMe Company Details
11.17.2 23andMe Business Overview
11.17.3 23andMe Personalized Medicines Introduction
11.17.4 23andMe Revenue in Personalized Medicines Business (2016-2021)
11.17.5 23andMe Recent Development
11.18 Illumina
11.18.1 Illumina Company Details
11.18.2 Illumina Business Overview
11.18.3 Illumina Personalized Medicines Introduction
11.18.4 Illumina Revenue in Personalized Medicines Business (2016-2021)
11.18.5 Illumina Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details